Document Detail

A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthma.
MedLine Citation:
PMID:  8930433     Owner:  NLM     Status:  MEDLINE    
A retrospective analysis of patient charts was performed for a single, multioffice pulmonary practice in Toronto, Ontario. Canada, to assess hospital care utilization and associated cost reductions after asthma prophylaxis with nedocromil sodium inhalation aerosol. Data were obtained from 310 adult patients with mild, moderate, or severe asthma who were treated in the practice between January 1988 and June 1994 and who had been placed on nedocromil sodium for at least 1 year. The number of office visits increased with nedocromil sodium therapy due to initial surveillance of the new medication, but no other changes were made in the usual protocol for each visit. After initiation of nedocromil sodium therapy, patients showed better asthma control as measured by improvements in pulmonary function scores and by reduced hospital utilization (both emergency department visits and hospital admissions). It is likely that the improvements in asthma control could result in cost savings, and savings projections for the Canadian health care system were made using the retrospective data collected for asthma-related hospital services. Prospective data are needed to confirm our findings.
P Thomas; R N Ross; J R Farrar
Related Documents :
8368463 - Regional distribution of asthma-related hospital treatment periods in finland in 1972-86.
19442103 - Predictors of "worsening renal function" in patients hospitalized in internal medicine ...
3591763 - Sudden and unexpected death. the pediatrician's response.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical therapeutics     Volume:  18     ISSN:  0149-2918     ISO Abbreviation:  Clin Ther     Publication Date:    1996 Sep-Oct
Date Detail:
Created Date:  1997-02-12     Completed Date:  1997-02-12     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  939-52     Citation Subset:  IM    
University of Toronto, Division of Respirology, St. Michael's Hospital, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Inhalation
Anti-Asthmatic Agents / administration & dosage,  economics,  therapeutic use*
Asthma / drug therapy*,  economics
Costs and Cost Analysis
Drug Prescriptions
Emergency Service, Hospital / utilization
Forced Expiratory Volume
Health Care Costs
Middle Aged
Nebulizers and Vaporizers / economics
Nedocromil / administration & dosage,  economics,  therapeutic use*
Peak Expiratory Flow Rate
Retrospective Studies
Reg. No./Substance:
0/Anti-Asthmatic Agents; 69049-73-6/Nedocromil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A review of health-related quality-of-life measures used in end-stage renal disease.
Next Document:  A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Di...